Question · asked by 1 review
CCBs vs beta‐blocker: All‐cause mortality
- Population
- patients with hypertension
- Intervention
- CCBs
- Comparison
- beta‐blocker
- Outcome
- All‐cause mortality
CCBs showed no clear difference in all‐cause mortality compared with β‐blocker (moderate certainty).
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
CCBs vs β‐blocker All‐cause mortality · patients with hypertension CCBs showed no clear difference in all‐cause mortality compared with β‐blocker (moderate certainty). Calcium channel blockers versus other classes of drugs for hypertension (2022) · Cochrane Headline outcomes only | RR 0.94 [0.88, 1] | 4 studies · 44825 participants | Moderate |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Calcium channel blockers versus other classes of drugs for hypertension 2022 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
Related questions
The same intervention and outcome, asked in another population or against another comparator.
- CCBs vs diuretics · patients with hypertension · 1 review
- CCBs vs ARB · patients with hypertension · 1 review
- CCBs vs ACE inhibitor · patients with hypertension · 1 review
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.